Literature DB >> 12568826

Validation of family history data in cancer family registries.

Argyrios Ziogas1, Hoda Anton-Culver.   

Abstract

BACKGROUND: Although family history information on cancer is used to infer risk of the disease in population-based, case-control, cohort, or family-based studies, little information is available on the accuracy of a proband's report. In this study, we sought to determine the validity of the reporting of family history of cancer by probands in population-based and clinic-based family registries of breast, ovarian, and colorectal cancers.
METHODS: To assess the accuracy of probands' reported family history of cancer in their relatives, we compared the family history from the personal interview of each proband to a reference standard that included pathology reports, self-reports, or death certificates on the relatives. Our study included 1111 families that accounted for 3222 relatives who were verified. To account for within-family correlations in the responses, we used a generalized estimating equation approach.
RESULTS: The probability of agreement between the proband-reported cancer status in a relative with the reference standard varied by cancer site and by degree of relationship to the proband. This probability for first-degree relatives was 95.4% (95% confidence interval [CI]=92.6-98.3) for female breast cancer; 83.3% (95% CI=72.8-93.8) for ovarian cancer; 89.7% (95% CI=85.4-94.0) for colorectal cancer; and 79.3% (95% CI=70.0-88.6) for prostate cancer.
CONCLUSIONS: We found high reliability of probands' reporting on most cancer sites when they reported on first-degree relatives and moderate reliability for their reporting on second- and third-degree relatives. Overreporting of cancer was rare (2.4%). Race or ethnicity and gender of the proband did not influence the accuracy of reporting. However, degree of relationship to the proband, type of cancer, age at diagnosis of the proband, and source of ascertainment of probands were statistically significant predictors of accuracy of reporting.

Entities:  

Mesh:

Year:  2003        PMID: 12568826     DOI: 10.1016/s0749-3797(02)00593-7

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  95 in total

1.  Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family Registry.

Authors:  A Joan Levine; Aung Ko Win; Daniel D Buchanan; Mark A Jenkins; John A Baron; Joanne P Young; Tiffany I Long; Daniel J Weisenberger; Peter W Laird; Rebecca L McCall; David J Duggan; Robert W Haile
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-05

2.  The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors.

Authors:  Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2010-05-04       Impact factor: 2.537

3.  Disparities in cancer screening in individuals with a family history of breast or colorectal cancer.

Authors:  Ninez A Ponce; Jennifer Tsui; Sara J Knight; Aimee Afable-Munsuz; Uri Ladabaum; Robert A Hiatt; Jennifer S Haas
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

4.  Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.

Authors:  Bhramar Mukherjee; John Oliver Delancey; Leon Raskin; Jessica Everett; Joanne Jeter; Colin B Begg; Irene Orlow; Marianne Berwick; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Hoda Anton Culver; Stefano Rosso; Roberto Zanetti; Peter A Kanetsky; Lynn From; Stephen B Gruber
Journal:  J Natl Cancer Inst       Date:  2012-04-24       Impact factor: 13.506

5.  Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer.

Authors:  Kerryn W Reding; David R Doody; Anne McTiernan; Li Hsu; Scott Davis; Janet R Daling; Peggy L Porter; Kathleen E Malone
Journal:  Breast Cancer Res Treat       Date:  2010-09-29       Impact factor: 4.872

6.  Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control study.

Authors:  Sara Villeneuve; Laurent Orsi; Alain Monnereau; Christian Berthou; Pierre Fenaux; Gerald Marit; Pierre Soubeyran; Françoise Huguet; Noël Milpied; Michel Leporrier; Denis Hemon; Xavier Troussard; Jacqueline Clavel
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

7.  Mammographic density and breast cancer risk by family history in women of white and Asian ancestry.

Authors:  Gertraud Maskarinec; Kaylae L Nakamura; Christy G Woolcott; Shannon M Conroy; Celia Byrne; Chisato Nagata; Giske Ursin; Celine M Vachon
Journal:  Cancer Causes Control       Date:  2015-03-12       Impact factor: 2.506

8.  Family history and age at onset of breast cancer in Hispanic and non-Hispanic white women.

Authors:  Betsy Risendal; Lisa M Hines; Carol Sweeney; Martha L Slattery; Anna R Giuliano; Kathy B Baumgartner; Karen Curtin; Tim E Byers
Journal:  Cancer Causes Control       Date:  2008-09-26       Impact factor: 2.506

9.  Survival after colorectal cancer diagnosis is associated with colorectal cancer family history.

Authors:  Jason A Zell; Jane Honda; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

Review 10.  Risk of pancreatic cancer in breast cancer families from the breast cancer family registry.

Authors:  Evelina Mocci; Roger L Milne; Elena Yuste Méndez-Villamil; John L Hopper; Esther M John; Irene L Andrulis; Wendy K Chung; Mary Daly; Saundra S Buys; Nuria Malats; David E Goldgar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.